Protocol to Obtain Blood Samples for Leukemia Research

Dartmouth Health

Status: Completed

Conditions: Chronic Lymphocytic Leukemia

Treatments: Other: No Intervention

Study type: Observational

Funder types: Other

Identifiers

NCT00889031

D0905

Details and patient eligibility

About

The purpose of this study is to collect a blood sample in patients with Chronic Lymphocytic Leukemia (CLL).

Full description

The blood sample will be used in the laboratory to perform studies focusing on Chronic Lymphocytic Leukemia (CLL).

Enrollment: 187 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients undergoing routine blood draws as part of their ongoing follow-up for Chronic Lymphocytic Leukemia (CLL) at the Norris Cotton Cancer Center of DHMC.

Exclusion criteria

• Patients who have received cytotoxic drug, oral or intravenous steroid or targeted antibody therapy for CLL or other disease process within the past 6 months are excluded. Use of intravenous immunoglobulin (IVIg) is not a reason for exclusion.

Trial design

187 participants in 1 patient group

No Treatment

Treatment:

Other: No Intervention